-
AIM Vaccine Integrates DeepSeek: Innovative Technology and Growth Potential Support Valuation Upside
PR Newswire
February 24, 2025
AIM Vaccine Co., Ltd. fully deploys DeepSeek large model, promoting its application in vaccine R & D, clinical, production, etc., with growth potential.
-
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX? Suspension Cell Line to Bolster MVA-Based Vaccine Development
B3C newswire
November 06, 2023
ProBioGen and GeoVax Labs, announce the signing of a landmark commercial license agreement for ProBioGen's groundbreaking AGE1.
-
Malaysian Genomics Pivots to Biopharmaceuticals for Growth
PharmaSources
March 07, 2023
Group reports lower revenue for 2Q on switch to immunotherapy and cell therapies from vaccines
-
New government plan to speed up elimination of cervical cancer
www.gov.cn
February 08, 2023
The central government has outlined a long-term plan to accelerate the elimination of cervical cancer by 2030 via an initiative aimed at boosting vaccination rates among girls.
-
Celonic to Become a Long-Term Partner of the Federal Republic of Germany for Vaccine Supply
b3cnewswire.com
March 28, 2022
The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and four other partners to secure the long-term supply of vaccines in Germany against Covid-19 and other pandemics...
-
Novavax files for Conditional Marketing Authorisation of COVID-19 vaccine in Switzerland
ExpressPharma
February 15, 2022
The submission for the regulatory evaluation of the vaccine includes data from two phase-III clinical trials.
-
Vaccine Effectiveness Up After Three COVID-19 Vaccine Doses
drugs.com
February 14, 2022
COVID-19 vaccine effectiveness (VE) is increased after three doses but wanes with time since vaccination after receipt of two or three...
-
AstraZeneca reports 41% growth in FY 2021 total revenue
Pharmaceutical-Technology
February 11, 2022
Total revenue for the Covid-19 sector was recorded at $4.11bn in FY 2021.
-
Mandatory COVID-19 Tests Lifted for Vaccinated Travelers to Britain
drugs.com
February 11, 2022
Vaccinated travelers will no longer have to take COVID-19 tests when they enter Britain, officials announced Friday.
-
Plant “biofactories” produce proteins for potential COVID-19 vaccine
EuropeanPharmaceuticalReview
February 10, 2022
COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 replicates by infecting human cells via the interaction of the receptor-binding domain (RBD) on the viral Spike (S) protein...